TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+17.97%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$215M
AUM Growth
+$215M
(-10%)
Cap. Flow
-$33.6M
Cap. Flow
% of AUM
-15.62%
Top 10 Holdings %
Top 10 Hldgs %
74.17%
Holding
41
New
12
Increased
7
Reduced
5
Closed
13
Top Buys
| 1 |
Baxter International
BAX
|
$25.1M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.4M |
| 3 |
Merck
MRK
|
$13.7M |
| 4 |
The Beauty Health Co
SKIN
|
$13.1M |
| 5 |
Sarepta Therapeutics
SRPT
|
$12.5M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$37.3M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$15.9M |
| 3 |
Protagonist Therapeutics
PTGX
|
$15.3M |
| 4 |
Johnson & Johnson
JNJ
|
$14.1M |
| 5 |
Cigna
CI
|
$12M |
Sector Composition
| 1 | Healthcare | 93.78% |
| 2 | Consumer Staples | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $28.6M | 11.38% | 261,500 +3,736 | +1% | +$409K |
|
|
2
Baxter International
BAX
$12.7B
| $25.1M | 9.98% | +312,400 | New | +$25.1M |
|
|
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
| $16.4M | 6.5% | +96,307 | New | +$16.4M |
|
|
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
| $14.7M | 5.85% | 312,847 -112,824 | -27% | -$5.31M |
|
5
Edwards Lifesciences
EW
$47.8B
| $13.9M | 5.53% | 122,880 +74,613 | +155% | +$8.45M |
|
|
6
Merck
MRK
$210B
| $13.7M | 5.43% | +181,765 | New | +$13.7M |
|
|
7
The Beauty Health Co
SKIN
$264M
| $13.1M | 5.21% | +504,606 | New | +$13.1M |
|
8
Medtronic
MDT
$119B
| $13M | 5.18% | 104,070 -80,610 | -44% | -$10.1M |
|
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $12.5M | 4.96% | +135,055 | New | +$12.5M |
|
10
Legend Biotech
LEGN
$6.41B
| $8.52M | 3.39% | +168,467 | New | +$8.52M |
|
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.44M | 3.35% | 13,950 -61,677 | -82% | -$37.3M |
|
12
Leap Therapeutics
LPTX
$12M
| $7.26M | 2.89% | +1,810,672 | New | +$7.26M |
|
|
EGRX
13
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.83M | 2.72% | 122,503 +27,581 | +29% | +$1.54M |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.13M | 2.44% | 377,708 +280,888 | +290% | +$4.56M |
|
15
United Therapeutics
UTHR
$13.8B
| $6.06M | 2.41% | +32,851 | New | +$6.06M |
|
|
BLU
16
DELISTED
BELLUS Health Inc.
BLU
| $5.97M | 2.37% | 972,997 +597,477 | +159% | +$3.67M |
|
17
Xenon Pharmaceuticals
XENE
$2.98B
| $4.04M | 1.6% | +264,134 | New | +$4.04M |
|
18
Cyclacel Pharmaceuticals
CYCC
$18.4M
| $2.76M | 1.1% | 522,943 +209,612 | +67% | +$1.1M |
|
|
SNCE
19
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $2.58M | 1.03% | 263,289 -6,583 | -2% | -$64.5K |
|
20
BioNTech
BNTX
$24B
| $1.5M | 0.6% | +5,506 | New | +$1.5M |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $1.45M | 0.58% | 148,355 -165,440 | -53% | -$1.62M |
|
22
Femasys
FEMY
$11.6M
| $1.31M | 0.52% | 190,600 +1,847 | +1% | +$12.7K |
|
23
Theravance Biopharma
TBPH
$699M
| $956K | 0.38% | +129,192 | New | +$956K |
|
|
CCXI
24
DELISTED
ChemoCentryx, Inc.
CCXI
| $274K | 0.11% | +16,045 | New | +$274K |
|
25
Aldeyra Therapeutics
ALDX
$351M
| – | – | -818,025 | Closed | -$9.27M |
|